Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
about
The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literatureAutoimmune bullous dermatoses in the elderly: an update on pathophysiology, diagnosis and management.Development of ocular disease in patients with mucous membrane pemphigoid involving the oral mucosaTreatment of autoimmune mucocutaneous blistering diseases with intravenous immunoglobulin therapy.Therapy of autoimmune bullous diseasesMucosal disease series. Number III. Mucous membrane pemphigoid.Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders.The use of i.v. IG therapy in dermatology.High-dose intravenous immunoglobulin (IVIG) therapy in autoimmune skin blistering diseases.The management of mucous membrane pemphigoid and pemphigus.Intravenous immunoglobulin therapy in autoimmune mucocutaneous blistering diseases: a review of the evidence for its efficacy and safety.Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: an update.Urban legend series: mucous membrane pemphigoid.Treatment of oral pemphigoid with intravenous immunoglobulin as monotherapy. Long-term follow-up: influence of treatment on antibody titres to human alpha6 integrin.A comparison of the periodontal status in patients with mucous membrane pemphigoid: a 5-year follow-up.Oral cyclophosphamide without corticosteroids to treat mucous membrane pemphigoid.[Mucous membrane pemphigoid].
P2860
Q28067526-144A1FEA-5BF0-4F7F-A346-8E6EEF4EA55EQ34615160-E5F48952-B680-48B7-B1FF-6414279EE391Q35761975-C2B810CF-891D-4631-A598-9CCCC763E8A0Q35842548-85CBF354-3BED-4884-A4B2-AD4CF6BF52E8Q35919150-E899E287-A769-4FB3-8F93-2E18528365D7Q36177681-8DB449E4-A038-45BA-872F-61838B9EA5B5Q36711702-E30C10CE-A703-41A1-8B48-68E6B7D566A2Q36794149-42B01B74-C331-4824-8ED0-E5BD07EEE25DQ36986054-A7A6ED8D-8DE2-4CD0-A71E-4AA5121FBE32Q37532013-B542C5EA-2E07-43AC-80E9-5C5AB2FA41E0Q37769572-8EF1F188-5F69-4218-968C-87776B84A47AQ37773986-196266B2-3BC9-4C4E-B69B-758D9A1FFE1FQ37933423-C7D1BCCA-2383-46DB-AF58-C5BF590750E7Q38169809-0DE60E75-516E-4A01-A252-FC4A49236659Q42525239-FC38EBB3-C4B0-4954-9132-001D90D7AEB3Q43244397-3B12BDBC-410B-4B74-9658-21046A36C816Q43789787-BF11D557-BE64-4526-8402-4554FD37B4A5Q49833864-9F79CE78-0353-4F06-9BBA-44286F32BC17
P2860
Comparison between intravenous immunoglobulin and conventional immunosuppressive therapy regimens in patients with severe oral pemphigoid: effects on disease progression in patients nonresponsive to dapsone therapy.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Comparison between intravenous ...... responsive to dapsone therapy.
@en
Comparison between intravenous ...... responsive to dapsone therapy.
@nl
type
label
Comparison between intravenous ...... responsive to dapsone therapy.
@en
Comparison between intravenous ...... responsive to dapsone therapy.
@nl
prefLabel
Comparison between intravenous ...... responsive to dapsone therapy.
@en
Comparison between intravenous ...... responsive to dapsone therapy.
@nl
P1433
P1476
Comparison between intravenous ...... responsive to dapsone therapy.
@en
P2093
P304
P356
10.1001/ARCHDERM.137.9.1181
P577
2001-09-01T00:00:00Z